Century Therapeutics Inc
IPSC
Get informed when a big investor buys or sells
+ FollowMarket Cap$161.02M
Close$
$-0.25
114.2% downside
Current Fair Value
114.2% downsideOvervalued by 114.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $161.02 Million |
|---|---|
| Enterprise Value | $146.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.11 |
| Beta | 1.6 |
| Outstanding Shares | 205,778,156 |
Return
| Return on Equity | -47.25% |
|---|---|
| Return on Assets | -38.25% |
| Return on Invested Capital | -44.11% |
Valuation & Multiples
| P/E Ratio | -1.79 |
|---|---|
| PEG | -28.97 |
| Price to Sales | - |
| Price to Book Ratio | 1.76 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.22 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$2.17 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$1.63 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7095▲ 70.95% |
|---|---|
| Total Calls | 189,300▲ 356.14% |
| Total Puts | 134,300▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 76.97%▼ 83.33% |
|---|---|
| Total Invested | $387.92M▲ 24.15% |
| Investors Holding | 105▲ 31.00% |
ESG Score
No data
About Century Therapeutics Inc
102 employees